Full Press Release Details
SAN FRANCISCO , Feb. 28, 2020 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR ) senior management is scheduled to present at the upcoming Cowen and Company 40th Annual Health Care Conference in Boston on Tuesday, March 3, 2020 at 9:20 a.m. Eastern Time .
The presentation will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: http://ir.nektar.com/events-and-presentations/events . This Webcast will be available for replay until April 3, 2020 .
About Nektar Nektar Therapeutics is a biopharmaceutical company with a robust, wholly-owned R&D pipeline of investigational medicines in oncology and immunology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California , with additional operations in Huntsville, Alabama and Hyderabad, India . Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com .
For Investors: Vivian Wu of Nektar Therapeutics 628-895-0661
SOURCE Nektar Therapeutics